AI Article Synopsis
- - There are currently 6 biologic agents approved for asthma treatment, all of which have been tested in strict clinical trials.
- - The rigid criteria used in these trials may not reflect how effective the treatments are in the real world.
- - This review examines real-world data on biologics for asthma, emphasizing indicators that can help predict how well patients might respond to these therapies.
Article Abstract
Presently, there are 6 biologic agents available for treatment of asthma. Each of these agents has undergone robust clinical trials in their approval programs. Such studies rely upon very rigid entry criteria that may not translate to real-world efficacy. Thus, exploring the efficacy of these agents in a larger, more heterogeneous, population brings a sense of comfort regarding their efficacy in the real-world. This review explores the available literature regarding the use of biologics in the real world, with a focus on markers of likely response to therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.iac.2024.07.007 | DOI Listing |
Publication Analysis
Top Keywords
real-world studies
4
studies biologics
4
biologics treatment
4
treatment moderate-to-severe
4
moderate-to-severe asthma
4
asthma presently
4
presently biologic
4
biologic agents
4
agents treatment
4
treatment asthma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!